Literature DB >> 16054514

Baker yeast-induced fever in young rats: characterization and validation of an animal model for antipyretics screening.

Jorgete Tomazetti1, Daiana Silva Avila, Ana Paula Oliveira Ferreira, Juliana Saibt Martins, Fabiane Rosa Souza, Carine Royer, Maribel Antonello Rubin, Marlí Redin Oliveira, Hélio Gauze Bonacorso, Marcos Antônio Pinto Martins, Nilo Zanatta, Carlos Fernando Mello.   

Abstract

In this study we describe a low-cost and reliable method for inducing fever in young male rats (28-30 days of age, 75-90 g), which seems suitable for the screening of new antipyretics. The effects of temperature measuring procedure-induced stress on the basal rectal temperature and on Baker yeast-induced hyperthermia was assessed. Rectal temperature (T) was recorded every hour for 12 h (07:00-19:00 h) with a lubricated thermistor probe. The animals were injected intraperitoneally with baker yeast (0.25, 0.135, 0.05 g/kg) or the equivalent volume of saline at 7:00 h. The administration of 0.135 g/kg baker yeast induced a sustained increase in rectal temperature for 4 h. Classical (dipyrone and acetaminophen) and novel (MPCA and FPCA) antipyretics, at doses that had no effect per se, reverted baker yeast-induced fever. The method presented induces a clear-cut fever, which is reverted by antipyretics commonly used in human beings and selected novel antipyretics in small animals. The method also allows antipyretic evaluation with low amount of drugs, due to the use of small animals and to the small variability of the pyretic response, which ultimately causes a significant reduction in the number of animals necessary for antipyretic evaluation. Therefore, this study describes an animal model of fever that is not only advantageous from the economical and technical point of view, but that also bears ethical concerns.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16054514     DOI: 10.1016/j.jneumeth.2005.03.002

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  15 in total

1.  Pharmacokinetic-pharmacodynamic modeling of the inhibitory effects of naproxen on the time-courses of inflammatory pain, fever, and the ex vivo synthesis of TXB2 and PGE2 in rats.

Authors:  Elke H J Krekels; Marie Angesjö; Ingemo Sjögren; Kristina Angeby Möller; Odd-Geir Berge; Sandra A G Visser
Journal:  Pharm Res       Date:  2011-02-23       Impact factor: 4.200

2.  N-Acetylcysteine prevents baker's-yeast-induced inflammation and fever.

Authors:  Ana Paula Oliveira Ferreira; Juliana Saibt Martins Pasin; André Luis Lopes Saraiva; Viviane Ratzlaff; Mateus Fortes Rossato; Rosália Andrighetto; Maribel Antonello Rubin; Juliano Ferreira; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2011-11-08       Impact factor: 4.575

3.  Antipyretic effect of phytol, possibly via 5KIR-dependent COX-2 inhibition pathway.

Authors:  Muhammad Torequl Islam
Journal:  Inflammopharmacology       Date:  2019-02-18       Impact factor: 4.473

4.  Antiinflammatory, Analgesic and Antipyretic Activities of Mimusops elengi Linn.

Authors:  A Purnima; B C Koti; A H M Thippeswamy; M S Jaji; A H M Vishwantha Swamy; Y V Kurhe; A Jaffar Sadiq
Journal:  Indian J Pharm Sci       Date:  2010-07       Impact factor: 0.975

5.  Pharmacological Basis for Traditional Use of the Lippia thymoides.

Authors:  Fabrício Souza Silva; Pedro Modesto Nascimento Menezes; Pedro Guilherme Souza de Sá; André Luís de Santana Oliveira; Eric Alencar Araújo Souza; Vinicius Martins Bamberg; Henrique Ribeiro de Oliveira; Sheilla Andrade de Oliveira; Roni Evêncio E Araújo; Ana Paula Trovatti Uetanabaro; Tânia Regina Dos Santos Silva; Jackson Roberto Guedes da Silva Almeida; Angélica Maria Lucchese
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-29       Impact factor: 2.629

6.  Emerging CAM Ziziphus nummularia with in vivo sedative-hypnotic, antipyretic and analgesic attributes.

Authors:  Abdur Rauf; Jawad Ali; Haroon Khan; Mohammad S Mubarak; Seema Patel
Journal:  3 Biotech       Date:  2016-01-05       Impact factor: 2.406

7.  In vivo evaluation of antipyretic effects of some homeopathic ultra-high dilutions on Baker's yeast-induced fever on Similia principle.

Authors:  Saeed Ahmad; Tayyeba Rehman; Waheed Mumtaz Abbasi
Journal:  J Ayurveda Integr Med       Date:  2017-12-06

8.  Diacerein decreases TNF-alpha and IL-1beta levels in peritoneal fluid and prevents Baker's yeast-induced fever in young rats.

Authors:  Juliana Saibt Martins Pasin; Ana Paula Oliveira Ferreira; André Luis Lopes Saraiva; Viviane Ratzlaff; Rosália Andrighetto; Jorgete Tomazetti; Daiana Silva Avila; Sydney Hartz Alves; Maribel Antonello Rubin; Juliano Ferreira; Adair Roberto Soares Santos; Carlos Fernando Mello
Journal:  Inflamm Res       Date:  2010-03       Impact factor: 4.575

9.  Pharmacological basis for the use of Hypericum oblongifolium as a medicinal plant in the management of pain, inflammation and pyrexia.

Authors:  Naila Raziq; Muhammad Saeed; Muhammad Shahid; Naveed Muhammad; Haroon Khan; Farah Gul
Journal:  BMC Complement Altern Med       Date:  2016-02-01       Impact factor: 3.659

10.  Analgesic and Antipyretic Activities of Methanol Extract and Its Fraction from the Root of Schoenoplectus grossus.

Authors:  Nirmal Kumar Subedi; S M Abdur Rahman; Mohammad Ahsanul Akbar
Journal:  Evid Based Complement Alternat Med       Date:  2016-02-11       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.